Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas
2005

D-type Cyclins in Colon Cancer

Sample size: 57 publication Evidence: moderate

Author Information

Author(s): Mermelshtein A, Gerson A, Walfisch S, Delgado B, Shechter-Maor G, Delgado J, Fich A, Gheber L

Primary Institution: Ben-Gurion University of the Negev and Soroka University Medical Center

Hypothesis

The study aims to characterize the expression of D-type cyclins in colon cancer and their relation to tumorigenesis.

Conclusion

Overexpression of cyclins D1 and D2 is linked to colon carcinogenesis, while cyclin D3 does not show a similar association.

Supporting Evidence

  • 44% of colon tumors showed overexpression of cyclin D1.
  • 53% of colon tumors showed overexpression of cyclin D2.
  • 35% of colon tumors showed overexpression of cyclin D3.
  • 16% of cases had reduced cyclin D3 expression compared to normal tissue.
  • Overexpression of cyclins D1 and D2 is linked to colon carcinogenesis.
  • Overexpression of cyclin D2 may relate to higher TNM stage of the tumor.

Takeaway

This study looked at proteins called D-type cyclins in colon cancer and found that two of them are often too high in cancer, which might help doctors understand the disease better.

Methodology

The study used Western blot analysis to examine D-type cyclin expression in tumor and adjacent normal colon tissues from patients and in colon cancer cell lines.

Limitations

The study could not link cyclin expression to tumor differentiation grades due to disproportionate distribution of tumor grades.

Participant Demographics

37 male and 20 female patients, mean age 66.5 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602709

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication